Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mycosis fungoides: association of KIR ligands and HLA-DQB1*05 with bad prognosis of the disease.

Journal of the European Academy of Dermatology and Venereology : JEADV - 1 Feb 2016

Brazzelli V, Rivetti N, Badulli C, Carugno A, Cananzi R, De Silvestri A, Martinetti M, Borroni G

Abstract excerpt

BACKGROUND: Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma. We previously reported that the prognosis of MF patients is not only related on clinical variables but it is also associated with peculiar HLA alleles. Until today, the association of HLA ligands for KIR with the prognosis of the disease has not yet been analysed. OBJECTIVE: We investigated the frequency of HLA ligands for killer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-DQ beta-Chains

Share to Ligands

Share to Mycosis Fungoides

Share to Prognosis

Share to Receptors, KIR

Share to Skin Neoplasms

Source

Identifiers

PMID: 25753140
DOI: 10.1111/jdv.13083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mycosis fungoides: association of KIR ligands and HLA-DQB1*05 with bad prognosis of the disease.PMID 25753140Read ↗

Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.Semantic proximity Read ↗

Genetic predisposition to early mycosis fungoides: investigating genetic polymorphisms in tissue-resident memory T-cell genes.Semantic proximity Read ↗

Pathogenic variants of mycosis fungoides identified using next-generation sequencing.Semantic proximity Read ↗

Mycosis fungoides: an updated review of clinicopathologic variants.Semantic proximity Read ↗

Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.Semantic proximity Read ↗

Mycosis fungoides: review of epidemiological observations.Semantic proximity Read ↗

Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern.Semantic proximity Read ↗

Null T-cell phenotype mycosis fungoides with aberrant CD20 and CD56 expression: A diagnostic dilemma.Semantic proximity Read ↗

Phenotypic heterogeneity of mycosis fungoides cells leads to the difficulties in determining tumour origin.Semantic proximity Read ↗

Analysis of differential β variable region of T cell receptor expression and NAV3/TNFRSF1B gene mutation in mycosis fungoides.Semantic proximity Read ↗

Intertriginous mycosis fungoides with T follicular helper cell phenotype progressing to Sézary syndrome.Semantic proximity Read ↗

Dysregulation of Plasma miR-146a and miR-155 Expression Profile in Mycosis Fungoides Is Associated with rs2910164 and rs767649 Polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.